S&P 500 7,591.70 −0.58%
Nasdaq 26,081.73 −0.65%
S&P/TSX 35,506.28 −1.11%
Apple 326.57 +3.56%
Nvidia 218.36 −2.37%
Microsoft 492.44 +0.16%
Shopify 175.14 +0.01%
Royal Bank 284.98 −0.21%
CAD/USD 0.7225 −0.26%
CLOSED · 02:10 ET
Market ClerkRecap
Fri Sep 11 · markets closed4 signals on Sep 10223 insider buys this week · $359.5MCIRO short report next: Sep 14The week ahead

CUE

Cue Biopharma, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
28.00
−2.50 −8.20%
USD · close Sep 10

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $203.4MP/E DIV YIELD FCF YIELD -24.66%REV TTM $37.7M +354.4%NET INCOME −$164.1MNET CASH $16.4M52W 5.31 – 36.78SEC XBRL · TTM TO Invalid Date

What CUE had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
No 8-K filings from CUE on record yet. The events worker reads new filings each morning; older ones appear as the sweep reaches them.

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch CUE. Know when insiders buy.
One email the day a filing lands. Free.